CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 98 filers reported holding CYTOSORBENTS CORP in Q1 2021. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $44,000 | -26.7% | 13,909 | -2.3% | 0.00% | – |
Q4 2021 | $60,000 | -49.6% | 14,233 | -2.8% | 0.00% | – |
Q3 2021 | $119,000 | +43.4% | 14,645 | +32.6% | 0.00% | – |
Q2 2021 | $83,000 | -39.0% | 11,044 | -29.1% | 0.00% | – |
Q1 2021 | $136,000 | -35.5% | 15,577 | -44.0% | 0.00% | – |
Q1 2019 | $211,000 | -18.5% | 27,819 | -13.4% | 0.00% | – |
Q4 2018 | $259,000 | -91.0% | 32,110 | -85.5% | 0.00% | -100.0% |
Q3 2018 | $2,862,000 | +710.8% | 221,897 | +617.5% | 0.00% | – |
Q2 2018 | $353,000 | – | 30,928 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
Avenir Corp | 150,600 | $580,000 | 0.06% |
HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |